Login / Signup
Şule Ketenci Ertaş
ORCID
Publication Activity (10 Years)
Years Active: 2019-2019
Publications (10 Years): 1
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ragıp Ertaş
,
Tomasz Hawro
,
Sabine Altrichter
,
Kemal Özyurt
,
Kemal Erol
,
Şule Ketenci Ertaş
,
Marcus Maurer
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU.
Allergy
75 (2) (2019)